Original Article

You have full text access to this OnlineOpen article

Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens

Potential consequences of granulocyte-colony-stimulating factor administration

  1. Jaime Morales-Arias MD1,†,*,
  2. Paul A. Meyers MD2,
  3. Marcela F. Bolontrade PhD1,
  4. Nidra Rodriguez MD1,
  5. Zhichao Zhou MD1,
  6. Krishna Reddy BS1,
  7. Alexander J. Chou MD2,
  8. Nadezhda V. Koshkina PhD1,
  9. Eugenie S. Kleinerman MD1

Article first published online: 10 AUG 2007

DOI: 10.1002/cncr.22964

Issue

Cancer

Cancer

Volume 110, Issue 7, pages 1568–1577, 1 October 2007

Additional Information

How to Cite

Morales-Arias, J., Meyers, P. A., Bolontrade, M. F., Rodriguez, N., Zhou, Z., Reddy, K., Chou, A. J., Koshkina, N. V. and Kleinerman, E. S. (2007), Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens. Cancer, 110: 1568–1577. doi: 10.1002/cncr.22964

Author Information

  1. 1

    Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York

  1. †

    Fax: (713) 792-0608

*Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 87, Houston, TX 77030

Publication History

  1. Issue published online: 14 SEP 2007
  2. Article first published online: 10 AUG 2007
  3. Manuscript Accepted: 24 MAY 2007
  4. Manuscript Revised: 19 MAY 2007
  5. Manuscript Received: 14 FEB 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (569K)

REFERENCES

  • 1
    Ginsberg JP,Woo SY,Johnson ME, et al. Ewing's sarcoma family of tumors: ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors.In:Pizzo PA,Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia: Lippincott, Williams and Wilkins; 2002: 973–974.
  • 2
    Horowitz M,Malawer MM,DeLaney TF, et al. Total body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol. 1993; 11: 1911–1918.
  • 3
    Wexler LH,DeLaney TF,Avila N, et al. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer. 1996; 78: 901–911.
    Direct Link:
  • 4
    Burdach S,Jurgens H,Peters C, et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol. 1993; 11: 1482–1488.
  • 5
    Terek R,Brien E,Marcove R, et al. Treatment of femoral Ewing's sarcoma. Cancer. 1996; 78: 70–78.
    Direct Link:
  • 6
    Bolontrade MF,Zhou RR,Kleinerman ES. Vasculogenesis plays a role in the growth of ewing's sarcoma in vivo. Clin Cancer Res. 2002; 8: 3622–3627.
  • 7
    Lee TH,Bolontrade MF,Worth LL, et al. Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34(+) stem cells into the expanding tumor vasculature. Int J Cancer. 2006; 119: 839–846.
    Direct Link:
  • 8
    Zhou Z,Zhou RR,Guan H, et al. E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model. Mol Cancer Ther. 2003; 2: 1313–1319.
  • 9
    Guan H,Zhou Z,Wang H, et al. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res. 2005; 11: 2662–2669.
  • 10
    Asano S. Human granulocyte colony-stimulating factor: its basic aspects and clinical applications. Am J Pediatr Hematol Oncol. 1991; 13: 400–413.
  • 11
    Heil G,Hoelzer D,Sanz MA, et al. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. Blood. 1997; 90: 4710–4718.
  • 12
    Bradstock K,Matthews J,Young G, et al. Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia. Leukemia. 2001; 15: 1331–1338.
  • 13
    Usuki K,Urabe A,Masaoka T, et al. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study. Br J Haematol. 2002; 116: 103–112.
    Direct Link:
  • 14
    Crawford J,Ozer H,Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991; 325: 164–170.
  • 15
    Freyer G,Ligneau B,Trillet-Lenoir V. Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia. Int J Antimicrob Agents. 1998; 10: 3–9.
  • 16
    Geng D,Joshi SK,Podolsky R, et al. GCSF receptor regulates antigen uptake and expression of cytokines and costimulatory molecules in dendritic cells. Mol Immunol. 2007; 44: 521–529.
  • 17
    Bussolino F,Colotta F,Bocchietto E, et al. Recent developments in the cell biology of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: activities on endothelial cells. Int J Clin Lab Res. 1993; 23: 8–12.
  • 18
    Bussolino F,Ziche M,Wang JM, et al. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest. 1991; 87: 986–995.
  • 19
    Calhoun DA,Christensen RD. Human developmental biology of granulocyte colony-stimulating factor. Clin Perinatol. 2000; 27: 559–576.
  • 20
    Tachibana M,Murai M. G-CSF production in human bladder cancer and its ability to promote autocrine growth: a review. Cytokines Cell Mol Ther. 1998; 4: 113–120.
  • 21
    Mueller MM,Fusenig NE. Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int J Cancer. 1999; 83: 780–789.
    Direct Link:
  • 22
    Steube KG,Meyer C,Drexler HG. Constitutive secretion of hematopoietic cytokines by human carcinoma cell lines and its up-regulation by interleukin-1 and phorbol ester. Oncol Rep. 1999; 6: 427–432.
  • 23
    Yang EX,Liu F,Xu Z, et al. Expression of granulocyte colony stimulating factor receptor in human colorectal cancer. Postgrad Med J. 2005; 81: 333–337.
  • 24
    Noda I,Fujieda S,Ohtsubo T, et al. Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines. Int J Cancer. 1999; 80: 78–84.
    Direct Link:
  • 25
    Mattei S,Colombo MP,Melani C, et al. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer. 1994; 56: 853–857.
    Direct Link:
  • 26
    Savarese TM,Mitchell K,McQuain C, et al. Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett. 2001; 162: 105–115.
  • 27
    Braun B,Lange M,Oeckler R, et al. Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization. J Neurooncol. 2004; 68: 131–140.
  • 28
    Mueller MM,Herold-Mende CC,Riede D, et al. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol. 1999; 155: 1557–1567.
  • 29
    Jordan JP,Hand CM,Markowitz RS, et al. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. J Neuroncol. 1992; 14: 19–35.
  • 30
    Natori T,Sata M,Washida M, et al. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun. 2002; 297: 1058–1061.
  • 31
    Obermueller E,Vosseler S,Fusenig NE, et al. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res. 2004; 64: 7801–7812.
  • 32
    Okazaki T,Ebihara S,Asada M, et al. Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models. Int Immunol. 2006; 18: 1–9.
  • 33
    Hirbe H,Uluckan O,Morgan E, et al. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood. 2007; 109: 3424–3431.
  • 34
    Lombaert IM,Wierenga PK,Kok T, et al. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clin Cancer Res. 2006; 12: 1804–1812.
  • 35
    Nienaber CA,Petzsch M,Kleine HD, et al. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans. Nat Clin Pract Cardiovasc Med. 2003; 3: S73–S77.
  • 36
    Kawada H,Takizawa S,Takanashi T, et al. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation. 2006; 113: 701–710.
  • 37
    Hicklin DJ,Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005; 23: 1011–1027.
  • 38
    Browder T,Butterfield CE,Kraling BM, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res. 2000; 60: 1878–1886.
  • 39
    Paris F,Fuks Z,Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 2001; 293: 293–297.
View Full Article (HTML) Get PDF (569K)